![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » McKesson Unveils PATH Pro Post-Acute Therapeutics Formulary Management Program
McKesson Unveils PATH Pro Post-Acute Therapeutics Formulary Management Program
McKesson has introduced the Path Pro Post-Acute Therapeutics Formulary Management Program for long-term care pharmacies.
Path Pro indicates which of the most commonly dispensed generic drugs in the LTC setting are preferred and non-preferred for geriatric patients — all with an eye toward helping reduce drug-related hospital readmissions.
McKesson collaborated with the Creighton University Center for Drug Information and Evidence Based Practice to create the program. Its key elements include a preferred drug list, preferred/non-preferred indication for geriatric patients and drug monographs. — Anisa Jibrell
Upcoming Events
-
21Oct